These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuroprotection in glaucoma - Is there a future role? Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165 [TBL] [Abstract][Full Text] [Related]
5. Glaucoma neuroprotection: What is it? Why is it needed? Weinreb RN Can J Ophthalmol; 2007 Jun; 42(3):396-8. PubMed ID: 17508033 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Hains BC; Waxman SG Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495 [TBL] [Abstract][Full Text] [Related]
8. [Neuroprotection in glaucoma]. Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I Oftalmologia; 2010; 54(2):7-10. PubMed ID: 20827905 [TBL] [Abstract][Full Text] [Related]
9. [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance]. Lengyel G; Zsolt T Orv Hetil; 2005 May; 146(18):839-42. PubMed ID: 15926629 [TBL] [Abstract][Full Text] [Related]
10. Saving the nerve from glaucoma: memantine to caspaces. Naskar R; Vorwerk CK; Dreyer EB Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579 [TBL] [Abstract][Full Text] [Related]
11. New strategies for Helicobacter pylori eradication. Selgrad M; Malfertheiner P Curr Opin Pharmacol; 2008 Oct; 8(5):593-7. PubMed ID: 18555746 [TBL] [Abstract][Full Text] [Related]
12. [What is the current role of clarithromycin in the eradication of Helicobacter pylori?]. Gisbert JP; Boixeda D; MartÃn de Argila C Rev Esp Enferm Dig; 1997 Apr; 89(4):305-12. PubMed ID: 9221019 [No Abstract] [Full Text] [Related]
13. Relevance of the site of injury of glaucoma to neuroprotective strategies. Levin LA Surv Ophthalmol; 2001 May; 45 Suppl 3():S243-9; discussion S273-6. PubMed ID: 11377443 [TBL] [Abstract][Full Text] [Related]
14. Clinical trials for glaucoma neuroprotection are not impossible. Quigley HA Curr Opin Ophthalmol; 2012 Mar; 23(2):144-54. PubMed ID: 22249238 [TBL] [Abstract][Full Text] [Related]
16. Eradication therapy for Helicobacter pylori. Vakil N; Megraud F Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602 [TBL] [Abstract][Full Text] [Related]
17. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation. Schwartz M; London A Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122 [TBL] [Abstract][Full Text] [Related]
18. [The role of apoptosis and proliferation of epitheliocytes in morphogenesis of Helicobacter pylori-associated gastritis]. Kogan EA; Bondarenko OIu; Sklianskaia OA; Lapina TL; Demura SA; Azov AG; Ivashkin VT Arkh Patol; 2003; 65(6):22-6. PubMed ID: 14964963 [TBL] [Abstract][Full Text] [Related]
19. Primary and secondary treatment for Helicobacter pylori in the United States. Vakil N Rev Gastroenterol Disord; 2005; 5(2):67-72. PubMed ID: 15976737 [TBL] [Abstract][Full Text] [Related]
20. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration. Neufeld AH J Glaucoma; 1998 Dec; 7(6):434-8. PubMed ID: 9871868 [No Abstract] [Full Text] [Related] [Next] [New Search]